Morphologic features of Candida dubliniensis on a modified Pal's medium. Preliminary study

Journal de Mycologie Medicale

Volumn 13, Issue 2, 2003, Pages 99-103

  Adou Bryn, K ^a   Douchet, C ^a   Ferrer, A ^a   Grimaud, L ^b   Robert, R ^b   Richard Lenoble, D ^a  

^a Lab Parasitol Mycol Med Trop   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

Candida dubliniensis; Chlamydospores; Diagnosis; Fungi; PAL's medium

Indexed keywords

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDIASIS; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIUM; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; LABORATORY DIAGNOSIS; MYCOSIS; NONHUMAN;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0038451513     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Anthony RM, Midgley J, Sweet SP, Howell SA. Multiple strains of Candida albicans in the oral cavity of HIV-positive and HIV-negative patients. Microb Ecol Health Dis 1995;8:23-30.
2. Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 1997;11:557-67.
3. Douchet C, Chandenier J, Barrabes A, Rherizol-Ferly M, Richard-Lenoble D. Reconnaissance rapide de colonies de Cryptococcus neoformans par une méthode simple. J Myc Med 1995;5:122-3.
4. Giammanco GM, Pignato S, Salvo S, Giammanco G. Carbohydrate assimilation profiles of the first Italian Candida dubliniensis clinical isolates recovered from an HIV-infected individual. Res Microbiol 2000;151:889-91.
5. Jabra-Rizk MA, Baqui AA, Kelley JI, Falkler WA, Merz WG, Meiller TF. Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol 1999;37:321-6.
6. Jabra-Rizk MA, Falkler Jr. WA, Merz WG, Baqui AA, Kelley JI, Meiller TF. Retrospective identification and characrerization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J Clin Microb 2000;38:2423-6.
7. Jabra-Rizk MA, Brenner TM, Romagnoli M, Baqui AA, Merz WG, Falkler WA, Meiller TF. Evaluation of a reformulated CHROMagar Candida. J Clin Microb 2001;39:2015-6.
8. Kurzai O, Korting HC, Harmsen D, Bautsch W, Molitor M, Frosch M, Mühlschlegel FA. Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis. J Mol Med 2000;78:521-9.
9. Marot-Leblond A, Grimaud L, Nail S, Bouterige S, Apaire-Marchais V, Sullivan DJ, Robert R. New monoclonal antibody specific for Candida albicans germ tube. J Clin Microb 2000;38:61-7.
10. Martin C, Roberts D, van Der Weide M, Rossau R, Jannes G, Smith T, Maher M. Development of a PCR-based line probe assay for identification of fungal pathogens. J Clin Microb 2000;38:3735-42.
11. McCullough M, Ross B, Reade P. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus. J Clin Microb 1995;33:696-700.
12. Moragues MD, Omaetxebarria MJ, Elguezabal N, Bikandi J, Quindos G, Coleman DC, Ponton J. Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections. J Clin Microb 2001;39:2999-3001.
13. Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, Coleman DC. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivates in vitro. Antimicrob Agents Chemother 1997;41:617-23.
14. Odds FC, Davidson A. "Room temperature" use of CHROMagar Candida. Diagn Microb Infect Dis 2000;38:147-50.
15. Pal M, Ono K, Goitsuka R, Hasegawa A. Isolation of Cryptococcus neoformans var. neoformans from canine otitis. Mycoses 1990;33:465-7.
16. Pal M. Feline meningitis due to Cryptococcus neoformans var. neoformans and review of feline cryptococcosis. Mycoses 1991;34:313-6.
17. Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D. Simple, inexpensive, reliable method for differenciation of Candida dubliniensis from Candida albicans. J Clin Microb 1998;36:2093-5.
18. Pujol C, Renaud F, Mallie M, de Meeus T, Bastide JM. Atypical strains of Candida albicans recovered from AIDS patients. J Med Vet Myc 1997;35:115-21.
19. Slifkin M. Tween 80 opacity test responses of various Candida species. J Clin Microb 2000;38:4626-28.
20. Staib P, Morschhäuser J. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 1999;42:521-4.
21. Staib F, Arastéh K. Chlamydospore formation on Staib agar. Observations made before Candida dubliniensis was described. Mycoses 2001;44:23-7.
22. Sullivan D, Bennett D, Henman M, Harwood P, Flint S, Mulcahy F, Shanley D, Coleman D. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microb 1993;31:2124-33.
23. Sullivan DJ, Westemeng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. Nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiol 1995;141:1507-21.
24. Sullivan DJ, Henman MC, Moran GP, O'Neill LC, Bennett DE, Shandley DB, Coleman DC. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J Med Microb 1996;44:399-408.
25. Sullivan D, Coleman D. Candida dubliniensis: Characteristics and identification. J Clin Microbiol 1998;36:329-34.
26. Tintelnot K, Haase G, Seibold M, Bergmann F, Staemmler M, Franz T, Naumann D. Evaluation of phenotypic markers for selection and identification Candida dubliniensis. J Clin Microb 2000;38:1599-608.
27. Verweij PE, Breuker IM, Rijs AJ, Meis JF. Comparative study of seven commercial yeast identification systems. J Clin Pathol 1999;52:271-3.